| National |
Apogen has taken over Sparkle Pharmaceuticals, an organization, which has been in active business of manufacturing various forms of pellets and has been catering to the needs of medium to big Pharmaceutical companies since 2007 in India.
Now Apogen targets to further expand its sales operations in India by adding Leading Indian Pharma companies to its customer list.
To realize this goal, Apogen has
|
|
Identified the gaps in therapeutic segments & expanded the product basket accordingly with the new & innovative products, |
|
Identified and linked up additional manufacturing capacity to cater to the enhanced demand |
|
Pooled up additional finance to meet the expanded business needs |
|
Since the Indian Pharma market is expected to grow at 10-15% CAGR for the next 5-10 years, we at Apogen identified India as a Key market in BRICS-MT pharmerging markets. To take advantage of this encouraging scenario, Apogen is planning to gear-up to cater to the unmet needs in R & D, Manufacturing, Sales & Marketing of Novel Drug Delivery Systems. |
|
| Apogen's Mantras of success |
|
- Built-in-Quality
- Customer service at its best
- WIN-WIN business model &
- Mutually beneficial LONG TERM association.
We look forward for agents & business associates across India for Immediate and Modified Release pellets.
Please Send your Market Enquiry |
